ArticleFrontiers in pharmacology2020

Tryptamine Attenuates Experimental Multiple Sclerosis Through Activation of Aryl Hydrocarbon Receptor.

Nicholas Dopkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.